Germany’s BfArM Joins SNOMED International for Nationwide Use of SNOMED CT

LONDON, Jan. 06, 2021 (GLOBE NEWSWIRE) — Germany's Federal Institute for Drugs and Medical Devices (BfArM) has announced their membership in SNOMED International for national use of SNOMED CT from the beginning of January 2021.

SNOMED CT, the world's most comprehensive clinical terminology and a recognized critical element for the electronic exchange of health data, is an important building block to achieve Germany's digitization initiative. Effective January 1, 2021, German users can register to request a free license for use of SNOMED CT by visiting the BfArM's National Release Center website.

BfArM President Prof. Dr. Karl Broich shares, "with SNOMED CT, the digitization of the healthcare system in Germany continues. As an international standardized health terminology, SNOMED CT is an important prerequisite for the reliable use and exchange of medical data from various sources to enable clinical and research activities. This is how we accelerate innovative developments and deliver new types of care options more quickly to patients."

Not all users in Germany will be new to SNOMED CT. In 2020, the Federal Ministry of Education and Research initiated a pilot license with a limited number of sub–licenses for Medical Informatics Initiative research participants and partners, an endeavor led by the TMF. Additionally, SNOMED International and Germany have, over the years, arranged for limited public good licenses allowing German clinicians, researchers and academics to experience the power of SNOMED CT. Now with full membership, all German institutions and specialist groups involved in the health care sector wishing to use SNOMED CT in their applications can apply for a free license from the BfArM.

Founded in 2007 by nine charter nations, SNOMED International is a not–for–profit organization that owns and maintains SNOMED CT, the world's most comprehensive clinical terminology. With over 350,000 concepts, SNOMED CT is not just a coding system of diagnosis. It also covers clinical findings like signs and symptoms and tens of thousands of surgical, therapeutic and diagnostic procedures. Also within the scope of SNOMED CT are observables and those concepts representing body structures, organisms, substances, pharmaceutical products, physical objects, physical forces, specimens, etc. needed to be recorded in or around the health record.

With SNOMED CT, users can record patient data more accurately, exchange patient data both within the health care team and with patients, both locally and across borders, to improve patient outcomes. Further, SNOMED CT can be used in health data and analytics platforms for clinical analytics, population analytics, management analytics, clinical research, applied research, and other research activities to improve health care.

SNOMED International CEO Don Sweete recognizes the dedication and work Germany has committed to formally begin their SNOMED CT journey. "With our global circumstance, 2021 is a year to showcase the power delivered by digital health," Don says. "Furthering Germany's digital health goals, SNOMED International membership will enable German users nationally to take advantage of augmented content areas such as Social Care and Social Determinants of Health, Genomics, Vaccines, and Devices. Due to SNOMED CT's polyhierarchical structure, Germany will be able to leverage SNOMED CT to engage in leading edge research and data analytics."

SNOMED International is proud to now work with 22 Members across Europe, and 40 Members globally. The addition of Germany to the organization further extends the reach of interoperable patient health information across Europe and broadens mature use of SNOMED CT to support German care delivery and clinical research.

For more information, please visit SNOMED International or the BfArM SNOMED CT website.

Media Contact:

Kelly Kuru
SNOMED International | Chief Communications Officer
(e) comms@snomed.org


GLOBENEWSWIRE (Distribution ID 8121478)

Germany’s BfArM Joins SNOMED International for Nationwide Use of SNOMED CT

LONDON, Jan. 06, 2021 (GLOBE NEWSWIRE) — Germany's Federal Institute for Drugs and Medical Devices (BfArM) has announced their membership in SNOMED International for national use of SNOMED CT from the beginning of January 2021.

SNOMED CT, the world's most comprehensive clinical terminology and a recognized critical element for the electronic exchange of health data, is an important building block to achieve Germany's digitization initiative. Effective January 1, 2021, German users can register to request a free license for use of SNOMED CT by visiting the BfArM's National Release Center website.

BfArM President Prof. Dr. Karl Broich shares, "with SNOMED CT, the digitization of the healthcare system in Germany continues. As an international standardized health terminology, SNOMED CT is an important prerequisite for the reliable use and exchange of medical data from various sources to enable clinical and research activities. This is how we accelerate innovative developments and deliver new types of care options more quickly to patients."

Not all users in Germany will be new to SNOMED CT. In 2020, the Federal Ministry of Education and Research initiated a pilot license with a limited number of sub–licenses for Medical Informatics Initiative research participants and partners, an endeavor led by the TMF. Additionally, SNOMED International and Germany have, over the years, arranged for limited public good licenses allowing German clinicians, researchers and academics to experience the power of SNOMED CT. Now with full membership, all German institutions and specialist groups involved in the health care sector wishing to use SNOMED CT in their applications can apply for a free license from the BfArM.

Founded in 2007 by nine charter nations, SNOMED International is a not–for–profit organization that owns and maintains SNOMED CT, the world's most comprehensive clinical terminology. With over 350,000 concepts, SNOMED CT is not just a coding system of diagnosis. It also covers clinical findings like signs and symptoms and tens of thousands of surgical, therapeutic and diagnostic procedures. Also within the scope of SNOMED CT are observables and those concepts representing body structures, organisms, substances, pharmaceutical products, physical objects, physical forces, specimens, etc. needed to be recorded in or around the health record.

With SNOMED CT, users can record patient data more accurately, exchange patient data both within the health care team and with patients, both locally and across borders, to improve patient outcomes. Further, SNOMED CT can be used in health data and analytics platforms for clinical analytics, population analytics, management analytics, clinical research, applied research, and other research activities to improve health care.

SNOMED International CEO Don Sweete recognizes the dedication and work Germany has committed to formally begin their SNOMED CT journey. "With our global circumstance, 2021 is a year to showcase the power delivered by digital health," Don says. "Furthering Germany's digital health goals, SNOMED International membership will enable German users nationally to take advantage of augmented content areas such as Social Care and Social Determinants of Health, Genomics, Vaccines, and Devices. Due to SNOMED CT's polyhierarchical structure, Germany will be able to leverage SNOMED CT to engage in leading edge research and data analytics."

SNOMED International is proud to now work with 22 Members across Europe, and 40 Members globally. The addition of Germany to the organization further extends the reach of interoperable patient health information across Europe and broadens mature use of SNOMED CT to support German care delivery and clinical research.

For more information, please visit SNOMED International or the BfArM SNOMED CT website.

Media Contact:

Kelly Kuru
SNOMED International | Chief Communications Officer
(e) comms@snomed.org


GLOBENEWSWIRE (Distribution ID 8121478)

LeddarTech Announces the Appointment of Carl-Peter Forster to Its Board of Directors

QUEBEC CITY, Jan. 06, 2021 (GLOBE NEWSWIRE) — LeddarTech , a global leader in Level 1–5 ADAS and AD sensing technology, is pleased to announce the appointment of Carl–Peter Forster to the Board of Directors, which further enhances the diversity and experience of the Board.

Carl–Peter Forster holds a degree in economics from Bonn University and a degree in aviation and space technology from the Technical University in Munich, Germany.

Carl–Peter has an extensive senior management background in the automotive industry with brands including BMW AG, in Munich, where he held various positions including Vice–President. He was also Managing Director of BMW South Africa, and a member of the board of BMW AG, responsible for global manufacturing, until 2000. Between 2001 and 2009, Carl–Peter was Managing Director of Adam Opel AG, then from 2006 President and CEO of General Motors Europe and a member of GM's Global Automotive Strategy board. From 2010 to 2011, he was Group CEO of Tata Motors (which included Jaguar Land Rover).

Since 2013, Carl–Peter has been a special advisor to the Chairman of the Geely Group, also holding board positions at Volvo Cars Group in Gothenburg (Sweden), Geely Automobile Holdings Ltd. (Hong Kong), as well as CEVT (the Geely engineering center in Gothenburg), and Chairman of The London Electric Vehicle Company (formerly The London Taxi Company) until 2019. In addition to serving as a board member for LeddarTech, Carl–Peter is currently Chairman of Chemring Plc, Chairman of the Shareholder Committee of Hella KGaA, and a member of the boards of IMI Plc, Babcock Plc, The Mobility House AG, Gordon Murray Design Ltd., Kinexon GmbH, Clear Motion Ltd., and Envisics Ltd.

"The LeddarTech Board of Directors is very pleased to welcome Carl–Peter Forster to the LeddarTech team", stated Mr. Michel Brl, chairman of the Board of LeddarTech. "Carl–Peter brings with him a wealth of industry experience as a leader with some of the world's largest automotive companies. Carl–Peter's extensive experience in the automotive industry as well as in ADAS and AD technology companies will be a tremendous asset to LeddarTech," Mr. Brl concluded.

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end–to–end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision sensor–fusion and perception platform and its cost–effective, scalable, and versatile LiDAR development solution for automotive–grade solid–state LiDARs based on the LeddarEngine, LeddarTech enables Tier 1–2 automotive system integrators to develop full–stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttle, truck, bus, delivery vehicle, smart city/factory, and robotaxi applications. The company is responsible for several innovations in cutting–edge automotive and mobility remote–sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:
Daniel Aitken, Vice–President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1–418–653–9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.


GLOBENEWSWIRE (Distribution ID 8120228)